Searched for
SANOFI AVENTIS SA
Stocks in the news: Tata Motors, Tech Mahindra, SBI, Lupin and IB HousingWith input costs continuing to rise, automaker like Tata Motors are looking to increase vehicle prices from January next year to offset the...- EU agrees to stop confiscation of Indian generic drugsEU has also come up with a draft, proposing changes in the customs regulations that would permanently take care of such seizures.
- Dr Reddy's launches Fexofenadine HCl in USDr Reddy's Laboratories today announced the launch of generic version of Allegra -- Fexofenadine HCl -- tablets in the US market.
- Indian generics to be safe from seizure while passing through EUPharma exporters can breathe easy as the European Union has finally agreed to India's demand to amend its Customs regulations to stop confi...
- Genzyme board rejects Sanofi $69-a-share offerBiotech firm Genzyme Corp. says its board of directors is rejecting Sanofi-Aventis SA's $69 a share offer and recommending Genzyme sharehol...
- Glenmark surges 12% on BSE on Sanofi-Aventis licensing pactShares of pharma firm Glenmark Pharmaceuticals today vaulted by 12 per cent on the Bombay Stock Exchange to touch a year-high of Rs 303.80 ...
- US court bans Sun from selling Eloxatin: Sanofi AventisFrench drug maker Sanofi Aventis SA on Friday said a New Jersey US district court ordered Sun Pharma to stop selling its generic version of...
- Hoechst to hike stake in Aventis to 60.37 pc for Rs 414.11 crDrug maker Aventis Pharma today said that one of its promoters, Hoechst GmbH, plans to hike stake in the company to 60.37 per cent by acqui...
- Sanofi-Aventis to buy Chattem for $1.9 bnFrench drug maker Sanofi-Aventis SA to buy US health care company Chattem Inc for about $1.9 billion in cash.
- Stocks to watch: Satyam, United Spirits, Bajaj AutoStocks are likely to open higher on Monday in line with global markets fuelled by expectations of a massive stimulus package in the United ...
- Piramal denies takeover bid by GlaxoGlaxoSmithKline is in early stages of discussions to acquire Indian generic drug maker Piramal Healthcare for around $1.5 billion.
- Glaxo in talks for Pirmal HealthcareBritish pharma major GlaxoSmithKline Plc is in early stages of discussions to acquire Indian generic drug maker Piramal Healthcare for arou...
- Glaxo in talks to buy India's Piramal Healthcare: Media reportBritish pharma major GlaxoSmithKline Plc is in discussions to acquire Indian generic drug maker Piramal Healthcare for nearly $1.5 billion,...
- Zentiva recommends shareholders reject Sanofi Aventis' bidThe board of Czech generic drugs maker Zentiva N.V. said it has recommended that its shareholders reject a takeover offer from French pharm...
- Sanofi, Abbott file lawsuit against GlenmarkSanofi-Aventis SA and Abbott Laboratories have jointly filed a lawsuit against Glenmark to prevent the Indian company from selling its hype...
- Bristol-Myers to shut half of its plants in 3 yearsApart from plant shutdowns, the company plans to lay off about 4,300 employees in a broad restructuring aimed at cost savings of $1.5 b by ...
- Bristol-Myers CEO in hot seat as board meet nearsPeter Dolan, Bristol-Myers Squibb’s embattled chief, spent his summer vacation in France cycling 350 miles in five days.
Load More- Indian generics to be safe from seizure while passing through EU
